Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Traded higher on solid quarterly results, reinforcing its position as a leader in outsourced drug development services. Although near-term growth...
— John W. Rogers
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Charles River Laboratories International, Inc.
Charles River Laboratories International, Inc. ($CRL), representing 3.4% of the composite, provides early-stage contract research services, animal models, and clinical discovery support for global pharmaceutical and biotechnology corporations. Ariel maintains a...
Charles River Laboratories ($CRL) provides essential preclinical laboratory testing, animal models, and drug discovery research services to biotechnology and pharmaceutical firms, accounting for 4.6% of fund assets. The manager maintains...
Charles River Laboratories ($CRL), which represents 3.9% of the fund's portfolio, is an essential contract research organization providing discovery and safety assessment services, laboratory products, and manufacturing support to the global biopharmaceutical industry. The manager holds...
More institutional theses from Ariel Appreciation Fund
OneSpaWorld Holdings ($OSW), holding a 2.6% position in the portfolio, is the dominant global provider of outsourced health, wellness, and spa services onboard luxury cruise vessels and destination resorts. The manager maintains...
Charles River Laboratories ($CRL), which represents 3.9% of the fund's portfolio, is an essential contract research organization providing discovery and safety assessment services, laboratory products, and manufacturing support to the global biopharmaceutical industry. The manager holds...
Haemonetics Corporation ($HAE), constituting 2.7% of the fund, develops and distributes specialized hematology technologies, blood management products, and plasma collection solutions. The manager is...